Dementia study in lab-grown cells finds Alzheimer’s skin cells handle stress differently
Alzheimer's and dementiaPart of a story we are following · 14 articles · See every update
If you worry about dementia, this study is not a reason to change anything today. It is early lab work that points scientists toward one possible clue. It has not been tested as a treatment or a test in people.
In a study of skin cells taken from people with Alzheimer’s disease and from control participants matched for age and sex, the Alzheimer’s cells responded to stress differently. Scientists found that a gene called PFKFB3 switched on less strongly in the Alzheimer’s cells. Weaker activity in that gene was linked to poorer thinking scores and higher levels of brain-damage markers in the blood.
How the study worked
Researchers grew skin cells (called fibroblasts) from people with Alzheimer’s and from control participants matched for age and sex, then stressed the cells with hydrogen peroxide and read their gene activity. The work was published November 18, 2026 in Geroscience. It was done in lab-grown cells, so it cannot tell us whether this pattern causes Alzheimer’s or only goes along with it.
What they found
Cells face stress all the time. Hydrogen peroxide mimics one kind of it, called oxidative stress, which comes from unstable oxygen molecules that can damage cells. Healthy cells usually adjust to it. The question here was whether Alzheimer’s cells adjust the same way.
They did not. The Alzheimer’s cells showed different patterns in several everyday cell jobs: handling stress inside the cell, immune activation, clearing out waste (called autophagy), making proteins, and controlling when cells divide.
From a long list of genes, the team singled out PFKFB3. In the Alzheimer’s cells, this gene turned up less when the cells were stressed. You can think of it as a smoke alarm that rings more quietly in some houses.
The team then compared this gene response with what was known about the people who gave the cells. Those with a weaker PFKFB3 response had poorer scores on thinking tests. They also had higher blood levels of three markers linked to brain-cell damage: plasma pTau217, neurofilament light chain, and glial fibrillary acidic protein.
Finally, the scientists turned down PFKFB3 in lab-grown human astrocytes, a type of support cell in the brain. Under oxidative stress, those cells survived less well. Their gene activity for protein care, energy use, and immune activation also shifted.
The authors describe PFKFB3 as a candidate. That means it is a lead worth following, not a proven cause.
What is still unknown
The study does not show that low PFKFB3 activity leads to Alzheimer’s. It does not show that raising it would help anyone. It also does not show that a skin-cell test could spot the disease early. Those are the next questions, and they would need studies in people.
What you can do today
There is no new action from this study, and current advice does not change. It did not test any test, food, habit, or medicine. Treat it as a small step in understanding how aging cells cope with stress, and read future results on PFKFB3 with the same calm.
For clinicians and researchers
Design: Preclinical ex vivo study of dermal fibroblasts from patients with Alzheimer’s disease and age- and sex-matched controls, exposed to hydrogen peroxide and analyzed by RNA sequencing; follow-up experiments used immortalized human astrocytes with PFKFB3 knockdown. Sample size not given in the abstract.
Main result: AD-derived fibroblasts showed distinct oxidative stress response patterns, with PFKFB3 showing reduced induction. Lower PFKFB3 responsiveness was associated with poorer cognitive performance and higher plasma pTau217, neurofilament light chain and glial fibrillary acidic protein. No effect sizes or confidence intervals are given.
Main limitation: Findings come from cultured peripheral fibroblasts and an immortalized astrocyte line, and the associations are correlational; the abstract gives no sample size or effect estimates.
How it fits: This cell-level work on stress responses in Alzheimer’s disease is mechanistically distant from the earlier articles on lecanemab in routine dementia care and caregiver positivity, so no direct relation can be drawn. Lecanemab shows results in real-life dementia care, with brain swelling rare · Patients on lecanemab did better when dementia caregivers felt more positive
Open question: Whether PFKFB3 responsiveness in fibroblasts predicts clinical progression, and whether modulating PFKFB3 alters stress vulnerability in neurons or glia in vivo, remains to be tested.
Cite this article
Mongevity Desk. Dementia study in lab-grown cells finds Alzheimer’s skin cells handle stress differently. Mongevity. Published November 21, 2026. Accessed November 22, 2026. https://mongevity.science/aging/2026/11/alzheimers-skin-cells-oxidative-stress-pfkfb3/Mongevity Desk. Dementia study in lab-grown cells finds Alzheimer’s skin cells handle stress differently [Internet]. Mongevity; 2026 Nov 21 cited 2026 Nov 22]. Available from: https://mongevity.science/aging/2026/11/alzheimers-skin-cells-oxidative-stress-pfkfb3/Mongevity Desk. (2026, November 21). Dementia study in lab-grown cells finds Alzheimer’s skin cells handle stress differently. Mongevity. https://mongevity.science/aging/2026/11/alzheimers-skin-cells-oxidative-stress-pfkfb3/
<a href="https://mongevity.science/aging/2026/11/alzheimers-skin-cells-oxidative-stress-pfkfb3/">Dementia study in lab-grown cells finds Alzheimer’s skin cells handle stress differently</a>
Free to share or quote with credit and a link.
Questions and answers
- Does this study show what causes Alzheimer's?
- No. It found that Alzheimer's skin cells respond to stress differently in the lab. It cannot show whether that difference causes the disease or goes along with it.
- What is PFKFB3?
- It is a gene that the researchers flagged as a stress-responsive candidate. In Alzheimer's skin cells it turned on less strongly when the cells were stressed.
- Is there a new test or treatment from this work?
- No. The study did not test either one. It points scientists toward PFKFB3 as a lead for future research.
- Why did researchers use skin cells?
- Skin cells from patients can keep some features linked to aging. They give scientists a way to study the disease without using brain tissue.





